A complex process involving a number of blood components, coagulation may be violated due to various internal/external factors or inherited, thus leading to a number of clotting disorders such as thrombocytopenia, hemophilia, hypoprothrombinemia, etc. If not treated, they may lead to severe complications (e.g. bleeding in the brain).
Continued technological advancements in the medical industry, ongoing innovations in the coagulation services and testing equipment, the increasing number of cases of coagulation disorders cases, introduction of new types of instruments, development of the hospital infrastructure stimulate the stable growth of the worldwide coagulation market. Abbott, Beckman Coulter, Biosite, Corgenix, Diagnostica Stago, Nanogen, ZyCare, Roche and Trinity Biotech recon amid the most recognized coagulation market participants. The U.S., Japan, Germany, Italy, Spain, France and the UK are among the largest markets for coagulation products and technologies.
A wealthy collection of the research reports covering the coagulation market at various geographical levels can be found in this MarketPublishers’ catalogue. Comprehensive assessment of the market, available in each study, includes data on the market size, shape, structure and trends. The researches characterize key factors influencing the market and outline future opportunities for the market. In addition, the reports evaluate the competitive pressure in the market and profile market leaders.
Publications found:
662
Sort by:
